Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 19
- M&A Activity
Cannara Biotech Acquires Medican Organic in $2.8m Deal, Cementing Quebec Cultivation Footprint
Cannara Biotech has completed its $2.8m all-cash acquisition of Medican Organic, finalising ownership of the Valleyfield cultivation operation it first acquired in 2021.
- US & Canada
‘Not Immediately Compliant’: What the CRS Says America’s Rescheduling Order Actually Delivers
Since President Trump issued an executive order to expedite cannabis rescheduling in December 2025, questions over the legal implications of this route have hung over the industry.
- Cannabis Daily News
Cannabis News Today — Thursday 7 May 2026: Rescheduling Pressure Builds as White House Sounds Potency Alarm
Today’s cannabis news is dominated by rescheduling momentum, with operators racing to secure DEA Schedule III status even as the White House raises fresh concerns over high-potency products, while the UK, Brazil and Idaho underline how rapidly access is broadening on multiple fronts.
- Markets & Stocks
Cannabis Stocks Today — Thursday 7 May 2026: Curaleaf Leads +9.4% as Sector Rallies
BoC Cannabis Index +1.67% on broad strength; Curaleaf +9.4% leads a 27-stock advance, IIPR -4.3% the day’s worst.
- CBD Market
America’s CBD Industry Now Faces Same Evidential Battle Europe Has Been Fighting for 8 Years
The long and arduous journey to regulate cannabidiol (CBD) in Europe, which began in 2018 with the European Union’s classification of CBD as a ‘novel food’, is now playing out in the courtrooms of the United States.
- M&A Activity
ACE Venture Completes 51% Acquisition of Vireo Health New York, Launching Boukét Cannabis Lifestyle Brand
ACE Venture has closed its 51% acquisition of Vireo Health New York, taking control of the vertically integrated medical operator and unveiling Boukét as a new cannabis lifestyle brand for the state.
- Markets & Stocks
Cannabis Stocks Today — Wednesday 6 May 2026: Innovative Industrial Properties Leads +14.03% as Sector Rallies
BoC Cannabis Index gains +1.26% as Innovative Industrial Properties surges +14.03%, lifting US MSOs and ETFs in a synchronised cannabis rally.
- Cannabis Daily News
Cannabis News Today — Wednesday 6 May 2026: Federal Pressure Mounts as UK Hits Medical Manufacturing Milestone
Trump targets hemp products, DEA pushes medical cannabis operators toward Schedule III registration, a major lawsuit hits industry therapeutic claims, Curaleaf marks a UK manufacturing first, and Virginia’s adult-use sales bill awaits the governor’s signature.
- Hemp Industry
DEA Formalises HHC Ban as US Farm Bill Offers No Repreive for Cannabinoid Market
As the federal campaign to clamp down on intoxicating hemp in the US rolls on, the Drug Enforcement Administration (DEA) has officially designated hexahydrocannabinol (HHC) a Schedule I substance.
- Medical Cannabis
Curaleaf Laboratories Becomes First UK Manufacturer of Medical Cannabis Suppositories and Pessaries
Curaleaf Laboratories Becomes First UK Manufacturer of Medical Cannabis Suppositories and Pessaries Curaleaf Laboratories today announced a significant milestone in the advancement of medical cannabis treatments in the United Kingdom, becoming the first licensed manufacturer in the country to develop and produce medical cannabis suppositories and pessaries.
- M&A Activity
Nabis Acquires Hudson Distribution Licence to Enter New Jersey Cannabis Market
Cannabis wholesale platform Nabis is acquiring Hudson Distribution Services’ New Jersey distribution licence and warehouse lease, marking its entry into a fourth US state.
- Cannabis Daily News
Cannabis News Today — Tuesday 5 May 2026: DEA Floodgates Open as Industry Races to Register
Cannabis drugmakers prepare for IPOs, nearly 400 operators rush to register with the DEA, microdosing data reframes consumer use patterns, and regulators from Israel to the Bahamas reshape their frameworks as Schedule III aftershocks ripple worldwide.
